BRCA1 promoter methylation in sporadic breast tumors: Relationship to gene expression profiles

Breast Cancer Research and Treatment

Volumn 91, Issue 2, 2005, Pages 179-186

  Matros, Evan ^a   Wang, Zhigang C ^a   Lodeiro, Gabriela ^c   Miron, Alexander ^a   Iglehart, J Dirk ^a,b   Richardson, Andrea L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NONE

Author keywords

Basal like breast cancer; BRCA1; Gene expression arrays; Methylation

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST ADENOMA; BREAST CARCINOGENESIS; CANCER GRADING; CLINICAL FEATURE; CONTROLLED STUDY; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; HERITABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MITOSIS INDEX; MITOSIS RATE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARRIER PROTEINS; CLUSTER ANALYSIS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; GENES, BRCA1; GENOTYPE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); UBIQUITIN-PROTEIN LIGASES;

EID: 18844410329     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-7603-8     Document Type: Article

References (48)

1. M Esteller MF Fraga M Guo J Garcia-Foncillas I Hedenfalk AK Godwin J Trojan C Vaurs-Barriere YJ Bignon S Ramus J Benitez T Caldes Y Akiyama Y Yuasa V Launonen MJ Canal R Rodriguez G Capella MA Peinado A Borg LA Aaltonen BA Ponder SB Baylin JG Herman 2001 DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis Hum Mol Genet 10 3001 3007
2. R Scully J Chen A Plug Y Xiao D Weaver J Feunteun T Ashley DM Livingston 1997 Association of BRCA1 with Rad51 in mitotic and meiotic cells Cell 88 265 275
3. T Taniguchi M Tischkowitz N Ameziane SV Hodgson CG Mathew H Joenje SC Mok AD D'Andrea 2003 Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors Nat Med 9 568 574
4. Y Wang D Cortez P Yazdi N Neff SJ Elledge J Qin 2000 BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures Genes Dev 14 927 939
5. R Scully SF Anderson DM Chao W Wei L Ye RA Young DM Livingston JD Parvin 1997 BRCA1 is a component of the RNA polymerase II holoenzyme Proc Natl Acad Sci USA 94 5605 5610
6. L Zheng LA Annab CA Afshari WH Lee TG Boyer 2001 BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor Proc Natl Acad Sci USA 98 9587 9592
7. A Bhattacharyya US Ear BH Koller RR Weichselbaum DK Bishop 2000 The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin J Biol Chem 275 23899 23903
8. PO Chappuis J Goffin N Wong C Perret P Ghadirian PN Tonin WD Foulkes 2002 A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer J Med Genet 39 608 610
9. SR Lakhani MJ Van De Vijver J Jacquemier TJ Anderson PP Osin L McGuffog DF Easton 2002 The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 2310 2318
10. OT Johannsson I Idvall C Anderson A Borg RB Barkardottir V Egilsson H Olsson 1997 Tumour biological features of BRCA1-induced breast and ovarian cancer Eur J Cancer 33 362 371
11. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 747 752
12. OI Olopade T Grushko 2001 Gene-expression profiles in hereditary breast cancer N Engl J Med 344 2028 2029
13. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lonning PO Brown AL Borresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423
14. ZC Wang M Lin LJ Wei C Li A Miron G Lodeiro L Harris S Ramaswamy DM Tanenbaum M Meyerson JD Iglehart A Richardson 2004 Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers Cancer Res 64 64 71
15. I Krop P Maguire J Lahti-Domenici G Lodeiro A Richardson HK Johannsdottir H Nevanlinna A Borg R Gelman RB Barkardottir A Lindblom K Polyak 2003 Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors Cancer Res 63 2024 2027
16. LJ van't Veer H Dai MJ van de Vijver YD He AA Hart M Mao HL Peterse K van der Kooy MJ Marton AT Witteveen GJ Schreiber RM Kerkhoven C Roberts PS Linsley R Bernards SH Friend 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530 536
17. I Hedenfalk D Duggan Y Chen M Radmacher M Bittner R Simon P Meltzer B Gusterson M Esteller OP Kallioniemi B Wilfond A Borg J Trent 2001 Gene-expression profiles in hereditary breast cancer N Engl J Med 344 539 548
18. PA Futreal Q Liu D Shattuck-Eidens C Cochran K Harshman S Tavtigian LM Bennett A Haugen-Strano J Swensen Y Miki 1994 BRCA1 mutations in primary breast and ovarian carcinomas Science 266 120 122
19. ME Thompson RA Jensen PS Obermiller DL Page JT Holt 1995 Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression Nat Genet 9 444 450
20. F Magdinier S Ribieras GM Lenoir L Frappart R Dante 1998 Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region Oncogene 17 3169 3176
21. K Miyamoto T Fukutomi K Asada K Wakazono H Tsuda T Asahara T Sugimura T Ushijima 2002 Promoter hypermethylation and post- transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers Jpn J Clin Oncol 32 79 84
22. Y Niwa T Oyama T Nakajima 2000 BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers Jpn J Cancer Res 91 519 526
23. A Perez-Valles M Martorell-Cebollada E Nogueira-Vazquez JA Garcia-Garcia E Fuster-Diana 2001 The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study J Clin Pathol 54 476 480
24. CA Wilson L Ramos MR Villasenor KH Anders MF Press K Clarke B Karlan JJ Chen R Scully D Livingston RH Zuch MH Kanter S Cohen FJ Calzone DJ Slamon 1999 Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas Nat Genet 21 236 240
25. Y Chen CF Chen DJ Riley DC Allred PL Chen D Von Hoff CK Osborne WH Lee 1995 Aberrant subcellular localization of BRCA1 in breast cancer Science 270 789 791
26. R Scully S Ganesan M Brown JA De Caprio SA Cannistra J Feunteun S Schnitt DM Livingston 1996 Location of BRCA1 in human breast and ovarian cancer cells Science 272 123 126
27. K Yoshikawa K Honda T Inamoto H Shinohara A Yamauchi K Suga T Okuyama T Shimada H Kodama S Noguchi AF Gazdar Y Yamaoka R Takahashi 1999 Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases Clin Cancer Res 5 1249 1261
28. JM Gudas T Li H Nguyen D Jensen FJ Rauscher 3rd KH Cowan 1996 Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells Cell Growth Differ 7 717 723
29. JP Vaughn PL Davis MD Jarboe G Huper AC Evans RW Wiseman A Berchuck JD Iglehart PA Futreal JR Marks 1996 BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells Cell Growth Differ 7 711 715
30. JC Rice H Ozcelik P Maxeiner I Andrulis BW Futscher 2000 Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens Carcinogenesis 21 1761 1765
31. A Catteau WH Harris CF Xu E Solomon 1999 Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics Oncogene 18 1957 1965
32. JC Rice KS Massey-Brown BW Futscher 1998 Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells Oncogene 17 1807 1812
33. S Staff J Isola M Tanner 2003 Haplo-insufficiency of BRCA1 in sporadic breast cancer Cancer Res 63 4978 4983
34. H Ozcelik MD To J Couture SB Bull IL Andrulis 1998 Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers Int J Cancer 77 1 6
35. PG Rio JC Maurizis M Peffault de Latour YJ Bignon DJ Bernard-Gallon 1999 Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene Int J Cancer 80 823 826
36. M Esteller JM Silva G Dominguez F Bonilla X Matias-Guiu E Lerma E Bussaglia J Prat IC Harkes EA Repasky E Gabrielson M Schutte SB Baylin JG Herman 2000 Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors J Natl Cancer Inst 92 564 569
37. S Signoretti L Di Marcotullio A Richardson S Ramaswamy B Isaac M Rue F Monti M Loda M Pagano 2002 Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer J Clin Invest 110 633 641
38. DA Porter IE Krop S Nasser D Sgroi CM Kaelin JR Marks G Riggins K Polyak 2001 A SAGE (serial analysis of gene expression) view of breast tumor progression Cancer Res 61 5697 5702
39. RY Wang CW Gehrke M Ehrlich 1980 Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues Nucleic Acids Res 8 4777 4790
40. M Frommer LE McDonald DS Millar CM Collis F Watt GW Grigg PL Molloy CL Paul 1992 A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands Proc Natl Acad Sci USA 89 1827 1831
41. JG Herman JR Graff S Myohanen BD Nelkin SB Baylin 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 9821 9826
42. SJ Clark J Harrison CL Paul M Frommer 1994 High sensitivity mapping of methylated cytosines Nucleic Acids Res 22 2990 2997
43. PM Warnecke C Stirzaker JR Melki DS Millar CL Paul SJ Clark 1997 Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA Nucleic Acids Res 25 4422 4426
44. A Miron JM Schildkraut BK Rimer EP Winer C Sugg Skinner PA Futreal D Culler B Calingaert S Clark P Kelly Marcom JD Iglehart 2000 Testing for hereditary breast and ovarian cancer in the southeastern United States Ann Surg 231 624 634
45. WE Highsmith Jr. Q Jin AJ Nataraj JM O'Connor VD Burland WR Baubonis FP Curtis N Kusukawa MM Garner 1999 Use of a DNA toolbox for the characterization of mutation scanning methods. I: construction of the toolbox and evaluation of heteroduplex analysis Electrophoresis 20 1186 1194
46. T Ganguly R Dhulipala L Godmilow A Ganguly 1998 High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families Hum Genet 102 549 556
47. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen T Hastie MB Eisen M van de Rijn SS Jeffrey T Thorsen H Quist JC Matese PO Brown D Botstein P Eystein Lonning AL Borresen-Dale 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874
48. N Turner A Tutt A Ashworth 2004 Hallmarks of 'BRCAness' in sporadic cancers Nat Rev Cancer 4 814 819